Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05505136 · ClinicalTrials.gov registry record

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes

A clinical trial, sponsored by Zoll Medical Corporation.

Completed
Registry status
62
Enrollment target

NCT05505136 is a clinical trial that has completed, run by Zoll Medical Corporation. The registered enrollment target is 62 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05505136 has completed, sponsored by Zoll Medical Corporation.

COMPLETED
Registry status
62 participants
Enrollment target

Study Summary

To determine the associations among biometric data and previously reported medication changes in the original MAPS study

Interventions

  • DEVICE Arrhythmia Management System (AMS)

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2022-08-30
Est. Completion 2023-05-15

Sponsor

Zoll Medical Corporation

24 total trials

What the Registry Record Tells You About NCT05505136

The ClinicalTrials.gov registry entry for NCT05505136 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Arrhythmia Management System (AMS) is the first listed.

NCT05505136 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05505136 about?

NCT05505136 is a clinical study titled "Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes". To determine the associations among biometric data and previously reported medication changes in the original MAPS study

What is the current status of trial NCT05505136?

This trial is currently completed. The enrollment target is 62 participants. The study started on 2022-08-30. Estimated completion is 2023-05-15.

What interventions are being tested in trial NCT05505136?

The interventions under investigation include: Arrhythmia Management System (AMS) (DEVICE).

Who is sponsoring clinical trial NCT05505136?

This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.